GlassScriptPhysician profile
James H Lee
NPI 1790280378
$3,040.49
in general payments reported to CMS, 2019-2025
11 companies · $922 in 2025
The $922 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $180 · 2023: $1,171 · 2024: $767 · 2025: $922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,860.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $725.81 | 2022-2023 | Intellis Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $539.10 | 2023-2025 | Intracept, Intracept Rf Probe |
| Stratus Medical, LLC | $508.50 | 2023-2024 | Nimbus |
| Intrinsic Therapeutics | $324.26 | 2025 | Barricaid Acd (Annular Closure Device) |
| Spr Therapeutics, INC | $268.47 | 2023-2025 | Sprint Pns System |
| Averitas Pharma INC. | $183.86 | 2023-2024 | Qutenza |
| Baxter Healthcare | $157.04 | 2024-2025 | Floseal |
| Nevro Corp. | $124.71 | 2023 | Senza |
| Vertex Pharmaceuticals Incorporated | $94.50 | 2025 | |
| Saluda Medical Americas, INC. | $93.33 | 2023 | Evoke Scs |
| Abbott Laboratories | $20.91 | 2025 | Perclose Prostyle |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.